Table of Content

Executive Summary
1 Market Overview
1.1 Cell Culture Technology
1.2 Historical Perspective of Cell Culture
1.3 Classification of Latin America Cell Culture Market
1.4 Market Footprint
1.5 Future Potential of the Latin America Cell Culture Market

2 Market Dynamics
2.1 Overview
2.2 Iceberg Analysis
2.3 Impact Analysis
2.4 Market Drivers
2.4.1 Increasing Incidence of Infectious Diseases Pressurizes Increasing Drug Discovery
2.4.2 Growing Demand for Monoclonal Antibodies (mAbs)
2.4.3 Growing Availability of Advanced Media Solutions
2.4.4 Increasing Government-funding for Cell-based Research
2.5 Market Restraints
2.5.1 Concerns for Scalability of Process
2.5.2 Ethical Concerns in the Production of Cell Culture Media
2.5.3 Lack of Skilled Personnel for Proper Handling of Culture Media
2.6 Market Opportunities
2.6.1 Insurgence of 3D Cell Cultures
2.6.2 Escalating Cases of Severe Chronic Diseases that Require Organ Transplantation

3 Competitive Landscape
3.1 Key Strategies and Developments
3.1.1 Product Launches and Enhancements
3.1.2 Synergistic Activities
3.1.3 Acquisitions, Approvals, and Expansion Activities
3.2 Market Share Analysis
3.3 Growth Share Analysis (Opportunity Mapping)
3.4 Industry Attractiveness
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of New Entrants
3.4.4 Threat of Substitute Products
3.4.5 Intensity of Competitive Rivalry

4 Latin America Cell Culture Market (by Product)
4.1 Overview
4.2 Consumables
4.2.1 Cell Culture Reagents and Supplements
4.2.2 Media
4.2.3 Sera
4.2.4 Plastic and Glass Consumables
4.3 Instruments

5 Latin America Cell Culture Market (by End User)
5.1 Overview
5.2 Biotechnology and Life-Sciences Companies
5.3 Pharmaceutical Companies
5.4 Academic and Research Institutes

6 Latin America Cell Culture Market (by Country)
6.1 Overview
6.2 Brazil
6.3 Mexico
6.4 Argentina
6.5 Chile
6.6 Colombia
6.7 Rest-of-Latin America

7 Company Profiles
7.1 Overview
7.2 Becton, Dickinson and Company
7.2.1 Company Overview
7.2.2 Role of Becton, Dickinson and Company in the Latin America Cell Culture Market
7.2.3 Financials
7.2.4 Key Insights about Financial Health of the Company
7.2.5 SWOT Analysis
7.3 CellGenix GmbH
7.3.1 Company Overview
7.3.2 Role of CellGenix GmbH in the Latin America Cell Culture Market
7.3.3 SWOT Analysis
7.4 Corning Incorporated
7.4.1 Company Overview
7.4.2 Role of Corning Incorporated in the Latin America Cell Culture Market
7.4.3 Financials
7.4.4 Key Insights about Financial Health of the Company
7.4.5 SWOT Analysis
7.5 Eppendorf AG
7.5.1 Company Overview
7.5.2 Role of Eppendorf AG in the Latin America Cell Culture Market
7.5.3 Financials
7.5.4 Key Insights about Financial Health of the Company
7.5.5 SWOT Analysis
7.6 Fujifilm Holdings Corporation
7.6.1 Company Overview
7.6.2 Role of Fujifilm Holdings Corporation in the Latin America Cell Culture Market
7.6.3 Financials
7.6.4 Key Insights about Financial Health of the Company
7.6.5 SWOT Analysis
7.7 General Electric Company
7.7.1 Company Overview
7.7.2 Role of General Electric Company in the Latin America Cell Culture Market
7.7.3 Financials
7.7.4 Key Insights about Financial Health of the Company
7.7.5 SWOT Analysis
7.8 Lonza Group AG
7.8.1 Company Overview
7.8.2 Role of Lonza Group AG in the Latin America Cell Culture Market
7.8.3 Financials
7.8.4 Key Insights about Financial Health of the Company
7.8.5 SWOT Analysis
7.9 Merck KGaA
7.9.1 Company Overview
7.9.2 Role of Merck KGaA in the Latin America Cell Culture Market
7.9.3 Financials
7.9.4 Key Insights about Financial Health of the Company
7.9.5 SWOT Analysis
7.10 Sartorius AG
7.10.1 Company Overview
7.10.2 Role of Sartorius AG in the Latin America Cell Culture Market
7.10.3 Financials
7.10.4 Key Insights about Financial Health of the Company
7.10.5 SWOT Analysis
7.11 Thermo Fisher Scientific Inc.
7.11.1 Company Overview
7.11.2 Role of Thermo Fisher Scientific Inc. in the Latin America Cell Culture Market
7.11.3 Financials
7.11.4 Key Insights about Financial Health of the Company
7.11.5 SWOT Analysis

8 Research Scope and Methodology
8.1 Report Scope
8.2 Latin America cell culture market: Research Methodology



List of Tables



Table 2.1: Impact Analysis of Market Drivers
Table 2.2: Impact Analysis of Market Restraints

List of Figures



Figure 1: Impact of Market Drivers and Market Restraints on the Latin America Cell Culture Market
Figure 2: Latin America Cell Culture Market Snapshot
Figure 3: Dominating Segments of the Latin America Cell Culture Market, 2017 and 2025
Figure 4: Latin America Cell Culture Market (by Product), 2017 and 2025
Figure 5: Latin America Cell Culture Market (by End User), 2017 and 2025
Figure 6: Latin America Cell Culture Market (by Country), 2017 and 2025
Figure 1.1: Evolution of Cell Culture
Figure 1.2: Classification of Latin America Cell Culture Market
Figure 1.3: Latin America Cell Culture Market, 2017-2025
Figure 2.1: Iceberg Analysis for Latin America Cell Culture Market
Figure 2.2: Number of Deaths by Communicable Diseases, 2016
Figure 2.3: Current Initiatives in Latin America (as of 2015)
Figure 2.4: Percentage of Adults (25-64-year-olds) with Educational Attainment in Latin America (2017)
Figure 2.5: Drivers for Increasing Acceptance of 3D Cell Culture Systems
Figure 3.1: Share of Key Developments and Strategies, January 2015 – January 2019
Figure 3.2: Share of Product Launches and Enhancements, January 2015 – January 2019
Figure 3.3: Share of Synergistic Activities, January 2015 – January 2019
Figure 3.4: Market Share Analysis for the Latin America Cell Culture Market, 2017
Figure 3.5: Market Share Analysis for the Latin America Cell Culture Market, 2018
Figure 3.6: Growth Share Matrix (Opportunity Mapping) for Latin America Cell Culture Market (by Companies), 2018
Figure 3.7: Overall Industry Attractiveness, 2018 and 2025
Figure 3.8: Overall Impact of Bargaining Power of Suppliers
Figure 3.9: Overall Impact of Bargaining Power of Buyers
Figure 3.10: Overall Impact of Threat of New Entrants
Figure 3.11: Overall Impact of Threat of Substitute Products
Figure 3.12: Overall Impact of Intensity of Competitive Rivalry
Figure 4.1: Latin America Cell Culture Market (by Product)
Figure 4.2: Latin America Cell Culture Market (by Product), 2017 and 2025
Figure 4.3: Latin America Cell Culture Market (by Consumables), 2017-2025
Figure 4.4: Latin America Cell Culture Market (by Types of Consumables), 2017-2025
Figure 4.5: Latin America Cell Culture Market (by Types of Cell Culture Reagents and Supplements), 2017-2025
Figure 4.6: Latin America Cell Culture Market (by Types of Media), 2017-2025
Figure 4.7: Latin America Cell Culture Market (by Sera), 2017-2025
Figure 4.8: Latin America Cell Culture Market (by Plastic and Glass Consumables), 2017-2025
Figure 4.9: Latin America Cell Culture Market (by Instruments), 2017-2025
Figure 4.10: Latin America Cell Culture Market (by Types of Instruments), 2017-2025
Figure 5.1: Latin America Cell Culture Market (by End User)
Figure 5.2: Latin America Cell Culture Market (by End User), 2017 and 2025
Figure 5.3: Latin America Cell Culture Market (by Biotechnology and Life-Sciences Companies), 2017-2025
Figure 5.4: Latin America Cell Culture Market (by Pharmaceutical Companies), 2017-2025
Figure 5.5: Latin America Cell Culture Market (by Academic and Research Institutes), 2017-2025
Figure 6.1: Latin America Cell Culture Market (by Country)
Figure 6.2: Latin America Cell Culture Market (by Country), 2017 and 2025
Figure 6.3: Brazil Cell Culture Market, 2017-2025
Figure 6.4: Mexico Cell Culture Market, 2017-2025
Figure 6.5: Argentina Cell Culture Market, 2017-2025
Figure 6.6: Chile Cell Culture Market, 2017-2025
Figure 6.7: Colombia Cell Culture Market, 2017-2025
Figure 6.8: Rest-of-Latin America Cell Culture Market, 2017-2025
Figure 7.1: Total Number of Companies Profiled
Figure 7.2: Becton, Dickinson and Company: Overall Product Portfolio
Figure 7.3: Becton, Dickinson and Company: Overall Financials, 2016-2018
Figure 7.4: Becton, Dickinson and Company: Revenue (by Segment), 2016-2018
Figure 7.5: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2016-2018
Figure 7.6: Becton, Dickinson and Company: Revenue (by Region), 2016-2018
Figure 7.7: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
Figure 7.8: Becton, Dickinson and Company: SWOT Analysis
Figure 7.9: CellGenix GmbH: Overall Product Portfolio
Figure 7.10: CellGenix GmbH: SWOT Analysis
Figure 7.11: Corning Incorporated: Overall Product Portfolio
Figure 7.12: Corning Incorporated: Overall Financials, 2016-2018
Figure 7.13: Corning Incorporated: Revenue (by Segments), 2016-2018
Figure 7.14: Corning Incorporated: Revenue (by Region), 2016-2018
Figure 7.15: Corning Incorporated: R&D Expenditure, 2016-2018
Figure 7.16: Corning Incorporated: SWOT Analysis
Figure 7.17: Eppendorf AG: Overall Product Portfolio
Figure 7.18: Eppendorf AG: Overall Financials, 2015-2017
Figure 7.19: Eppendorf AG: Revenue (by Region), 2015-2017
Figure 7.20: Eppendorf AG: R&D Expenditure, 2015-2017
Figure 7.21: Eppendorf AG: SWOT Analysis
Figure 7.22: Fujifilm Holdings Corporation: Overall Product Portfolio
Figure 7.23: Fujifilm Holdings Corporation: Overall Financials, 2015-2017
Figure 7.24: Fujifilm Holdings Corporation: Revenue (by Segment), 2015-2017
Figure 7.25: Fujifilm Holdings Corporation: Revenue (by Region), 2015-2017
Figure 7.26: Fujifilm Holdings Corporation: R&D Expenditure, 2015-2017
Figure 7.27: Fujifilm Holdings Corporation: SWOT Analysis
Figure 7.28: General Electric Company: Overall Product Portfolio
Figure 7.29: General Electric Company: Overall Financials, 2016-2018
Figure 7.30: General Electric Company - Revenue (by Segment), 2016-2018
Figure 7.31: General Electric Company (GE Healthcare) - Revenue (by Segment), 2016-2018
Figure 7.32: General Electric Company: Revenue (by Region), 2016-2018
Figure 7.33: General Electric Company (GE Healthcare): Revenue (by Region), 2016-2018
Figure 7.34: General Electric Company: R&D Expenditure, 2016-2018
Figure 7.35: General Electric Company: SWOT Analysis
Figure 7.36: Lonza Group AG: Overall Product Portfolio
Figure 7.37: Lonza Group AG: Overall Financials, 2016-2018
Figure 7.38: Lonza Group AG: Revenue (by Segment), 2016-2018
Figure 7.39: Lonza Group AG: Revenue (by Region), 2016-2018
Figure 7.40: Lonza Group AG: R&D Expenditure, 2016-2018
Figure 7.41: Lonza Group AG: SWOT Analysis
Figure 7.42: Merck KGaA: Overall Product Portfolio
Figure 7.43: Merck KGaA: Overall Financials, 2016-2018
Figure 7.44: Merck KGaA: Revenue (by Segment), 2016-2018
Figure 7.45: Merck KGaA: Revenue (by Region), 2016-2018
Figure 7.46: Merck KGaA: Life Science Segment Revenue (by Region), 2016-2018
Figure 7.47: Merck KGaA: R&D Expenditure, 2016-2018
Figure 7.48: Merck KGaA: SWOT Analysis
Figure 7.49: Sartorius AG: Overall Product Portfolio
Figure 7.50: Sartorius AG: Overall Financials, 2016-2018
Figure 7.51: Sartorius AG: Revenue (by Segment), 2016-2018
Figure 7.52: Sartorius AG: Revenue (by Region), 2016-2018
Figure 7.53: Sartorius AG: R&D Expenditure, 2016-2018
Figure 7.54: Sartorius AG: SWOT Analysis
Figure 7.55: Thermo Fisher Scientific Inc.: Overall Product Portfolio
Figure 7.56: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 7.57: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 7.58: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 7.59: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 7.60: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 8.1: Latin America Cell Culture Market Segmentation
Figure 8.2: Latin America Cell Culture Market Research Methodology
Figure 8.3: Primary Research
Figure 8.4: Secondary Research
Figure 8.5: Data Triangulation
Figure 8.6: Bottom-up Approach (Segment-wise Analysis)
Figure 8.7: Top-down Approach (Segment-wise Analysis)
Figure 8.8: Assumptions and Limitations
Figure 8.9: Considered Factors for Data Prediction and Modelling